10/09/2026
🎗️ Could some cancer treatment in Kenya become dramatically cheaper?
A new Pfizer–KEMSA deal is expected to bring down the price of selected cancer medicines — in some cases from as much as KSh1 million to below KSh50,000 per cycle.
The medicines cover cancers including breast, colorectal, lung, prostate, stomach and oesophageal cancers, as well as some blood cancers.
That sounds like a huge win.
But here's the question we should be asking:
Will the lower prices actually translate into affordable, accessible treatment for patients?
Because announcing a cheaper medicine is one thing. Making sure patients can actually get it — and that SHA coverage works as intended — is another.
We break down what the deal could mean for cancer patients in Kenya. 👇
Follow AfyaWatch254 for Kenyan health news without the noise.